Canada Markets closed

Johnson & Johnson (JNJ)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
162.37-0.41 (-0.25%)
At close: 3:59PM EST

162.98 +0.61 (0.38%)
After hours: 4:05PM EST

Full screen
Trade prices are not sourced from all markets
Previous Close162.78
Bid162.53 x 800
Ask162.56 x 800
Day's Range161.81 - 164.14
52 Week Range109.16 - 164.14
Avg. Volume7,423,637
Market Cap427.445B
Beta (5Y Monthly)0.70
PE Ratio (TTM)25.53
EPS (TTM)6.36
Earnings DateJan. 26, 2021
Forward Dividend & Yield4.04 (2.48%)
Ex-Dividend DateFeb. 22, 2021
1y Target Est167.59
  • The OUTstanding Top 100 LGBT+ Future Leaders 2020
    Yahoo Finance UK

    The OUTstanding Top 100 LGBT+ Future Leaders 2020

    All of the future leaders in this list — who, once they identify as LGBT+, can be in any position in a company, can be any nationality, and based in any country — were nominated by peers and colleagues, or put themselves forward.

  • J&J's (JNJ) Darzalex Faspro Gets FDA Nod for Amyloidosis

    J&J's (JNJ) Darzalex Faspro Gets FDA Nod for Amyloidosis

    J&J (JNJ) gets accelerated approval for a new indication of Darzalex Faspro in combination with bortezomib, cyclophosphamide and dexamethasone for treating amyloidosis patients.

  • Reuters

    South Africa is promised 9 million J&J vaccine shots - Business Day

    South Africa, which has yet to receive its first coronavirus vaccine, has been promised 9 million doses by Johnson & Johnson, the Business Day newspaper reported on Monday, citing a health ministry spokeswoman. The government of Africa's most advanced economy is scrambling to secure enough COVID-19 vaccines, after health workers and scientists publicly criticised it for not moving fast enough to inoculate its people. The country has recorded more than 1.3 million infections and more than 37,000 deaths related to the virus, the most in Africa.